Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea
Launched by UNIVERSITY HOSPITAL OSTRAVA · Aug 1, 2016
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Materials and Methods The study was approved by the Institutional Ethics Committee and performed in accordance with the Declaration of Helsinki, good clinical practice, and applicable regulatory requirements. Informed written consent was obtained from all participants before initiation of any procedure.
• History, otorhinolaryngology examination, polysomnography Patient history will be taken with emphasis on snoring and OSA symptoms. Daytime sleepiness will be assessed using the Epworth Sleepiness Scale. Moreover, patients will be asked to grade the severity of snoring on a 10-point Visual...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years
- • obstructive sleep apnoea (mild, moderate Apnea-Hypopnea Index (AHI) \<15)
- • severe OSA - failed CPAP treatment
- • severe OSA - patients whorefused CPAP
- Exclusion Criteria:
- • ASA 4 (classification of the American Society of Anesthesiologists)
- • pregnancy
- • propofol or midazolam allergies
- • other significant disease with current decompensation
About University Hospital Ostrava
University Hospital Ostrava is a leading medical research institution located in Ostrava, Czech Republic, dedicated to advancing healthcare through innovative clinical trials and research initiatives. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a focus on ethical standards and regulatory compliance, University Hospital Ostrava aims to contribute to the development of new therapies and improve treatment outcomes across various medical fields. Its robust research infrastructure and dedication to scientific excellence position it as a key player in the advancement of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ostrava, , Czechia
Patients applied
Trial Officials
Pavel Komínek, prof.MD,PhD,MBA
Study Director
University Hospital Ostrava
Jaroslava Hybášková, MD
Principal Investigator
University Hospital Ostrava
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials